Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296550718> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4296550718 endingPage "208" @default.
- W4296550718 startingPage "195" @default.
- W4296550718 abstract "DNA topoisomerases are a class of ubiquitous enzymes that maintain the topological structures of DNA in both prokaryotic and eukaryotic organisms. The enzymes catalyze DNA topoisomerization reactions through a sequential DNA breaking passing-resealing process, and are the targets of many important therapeutic agents for the treatment of cancer and bacterial infectious diseases. Quinolone antibacterial agents are known to target specifically to DNA gyrase, a bacterial type II DNA topoisomerase. The drugs have rapid bactericidal action that is believed to derive from their dual actions to inhibit the catalytic activity of the essential enzyme and, more importantly, to form a stable enzyme-DNA cleavable complex at a position ahead of the replication forks leading to a quick arrest of DNA replication, irreversible DNA damage and thus cell death. These inhibitors are small in size and simple in structure, but are extremely potent with the antibacterial potency reaching to a few nanograms per milliliter range. The high potency and specificity of these inhibitors is believed to be achieved by its unique capability to bind cooperatively to a partially denatured DNA pocket created by the target enzyme during the strand breaking passing steps of the catalysis. The inhibition model emphasizes the importance of the binding pocket conformation in determining the binding specificity and potency. This 'conformation-fitting model ' explains most structure-activity relationships of quinolones as well as observations in quinolone-resistance patterns. Recent publications imply that the target of quinolones may also be the bacterial topoisomerase IV, which is another essential type II enzyme discovered recently in E. coli and shown to be necessary for DNA segregation at the final stage of cell division. These two enzymes share high degree of sequence homology as well as quinolone sensitivity in vitro and in vivo. Results of genetic analysis of resistant mutants further support the notion that topoisomerase IV may be a primary target of quinolone action in Staphylococcus aureus." @default.
- W4296550718 created "2022-09-21" @default.
- W4296550718 creator A5022513094 @default.
- W4296550718 creator A5065112951 @default.
- W4296550718 date "1996-04-01" @default.
- W4296550718 modified "2023-10-16" @default.
- W4296550718 title "Type II DNA Topoisomerases as Antibacterial Targets" @default.
- W4296550718 doi "https://doi.org/10.2174/1381612802666220921174531" @default.
- W4296550718 hasPublicationYear "1996" @default.
- W4296550718 type Work @default.
- W4296550718 citedByCount "29" @default.
- W4296550718 countsByYear W42965507182014 @default.
- W4296550718 countsByYear W42965507182019 @default.
- W4296550718 countsByYear W42965507182020 @default.
- W4296550718 countsByYear W42965507182021 @default.
- W4296550718 countsByYear W42965507182022 @default.
- W4296550718 countsByYear W42965507182023 @default.
- W4296550718 crossrefType "journal-article" @default.
- W4296550718 hasAuthorship W4296550718A5022513094 @default.
- W4296550718 hasAuthorship W4296550718A5065112951 @default.
- W4296550718 hasConcept C104317684 @default.
- W4296550718 hasConcept C147897179 @default.
- W4296550718 hasConcept C158456008 @default.
- W4296550718 hasConcept C167125095 @default.
- W4296550718 hasConcept C181199279 @default.
- W4296550718 hasConcept C185592680 @default.
- W4296550718 hasConcept C2777112418 @default.
- W4296550718 hasConcept C2778616834 @default.
- W4296550718 hasConcept C2779922871 @default.
- W4296550718 hasConcept C501593827 @default.
- W4296550718 hasConcept C547475151 @default.
- W4296550718 hasConcept C552990157 @default.
- W4296550718 hasConcept C55493867 @default.
- W4296550718 hasConcept C73573662 @default.
- W4296550718 hasConcept C86803240 @default.
- W4296550718 hasConcept C98086919 @default.
- W4296550718 hasConceptScore W4296550718C104317684 @default.
- W4296550718 hasConceptScore W4296550718C147897179 @default.
- W4296550718 hasConceptScore W4296550718C158456008 @default.
- W4296550718 hasConceptScore W4296550718C167125095 @default.
- W4296550718 hasConceptScore W4296550718C181199279 @default.
- W4296550718 hasConceptScore W4296550718C185592680 @default.
- W4296550718 hasConceptScore W4296550718C2777112418 @default.
- W4296550718 hasConceptScore W4296550718C2778616834 @default.
- W4296550718 hasConceptScore W4296550718C2779922871 @default.
- W4296550718 hasConceptScore W4296550718C501593827 @default.
- W4296550718 hasConceptScore W4296550718C547475151 @default.
- W4296550718 hasConceptScore W4296550718C552990157 @default.
- W4296550718 hasConceptScore W4296550718C55493867 @default.
- W4296550718 hasConceptScore W4296550718C73573662 @default.
- W4296550718 hasConceptScore W4296550718C86803240 @default.
- W4296550718 hasConceptScore W4296550718C98086919 @default.
- W4296550718 hasIssue "2" @default.
- W4296550718 hasLocation W42965507181 @default.
- W4296550718 hasOpenAccess W4296550718 @default.
- W4296550718 hasPrimaryLocation W42965507181 @default.
- W4296550718 hasRelatedWork W1532804341 @default.
- W4296550718 hasRelatedWork W1566237970 @default.
- W4296550718 hasRelatedWork W1979474715 @default.
- W4296550718 hasRelatedWork W1982283131 @default.
- W4296550718 hasRelatedWork W2120064025 @default.
- W4296550718 hasRelatedWork W2132697669 @default.
- W4296550718 hasRelatedWork W2320865961 @default.
- W4296550718 hasRelatedWork W2891754900 @default.
- W4296550718 hasRelatedWork W4296550718 @default.
- W4296550718 hasRelatedWork W654517534 @default.
- W4296550718 hasVolume "2" @default.
- W4296550718 isParatext "false" @default.
- W4296550718 isRetracted "false" @default.
- W4296550718 workType "article" @default.